ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.6314
0.00%
Brent Oil
76.495
0.00%
Bitcoin
98,074.56
-0.14%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Syntheticmr Ab (publ) (0G79) Cotización

Syntheticmr Ab (publ)

Syntheticmr Ab (publ) (0G79)

LSE
350.00
0.00
(0.00%)
Cerrado 04 Enero 10:30AM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
350.00
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
0.00
0.00 Rango del Día 0.00
350.00 Rango de 52 semanas 350.00
Capitalización de Mercado [m]
14.578B
Precio Anterior
350.00
Precio de Apertura
-
Hora
(O)
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
0.00
Acciones en circulación
41,651,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
1,455.91
Beneficio por acción (BPA)
0.24
turnover
89.21M
Beneficio neto
10.01M

Acerca de Syntheticmr Ab (publ)

Sector
Medical Laboratories
Industria
Medical Laboratories
Sitio web
www.syntheticmr.com
Sede
Stockholm, Swe
Fundado
-
Syntheticmr Ab (publ) is listed in the Medical Laboratories sector of the London Stock Exchange with ticker 0G79. The last closing price for Syntheticmr Ab (publ) was SEK350. Over the last year, Syntheticmr Ab (publ) shares have traded in a share price range of SEK 350.00 to SEK 350.00.

Syntheticmr Ab (publ) currently has 41,651,000 shares in issue. The market capitalisation of Syntheticmr Ab (publ) is SEK14.58 billion. Syntheticmr Ab (publ) has a price to earnings ratio (PE ratio) of 1455.91.

0G79 Últimas noticias

Más noticias

SyntheticMR receives FDA 510(k) clearance for SyMRI 15

SyntheticMR receives FDA 510(k) clearance for SyMRI 15 PR Newswire LINKÖPING, Sweden, Dec. 6, 2024 LINKÖPING, Sweden, Dec. 6, 2024 /PRNewswire/ -- SyntheticMR, leader in quantitative imaging...

06 Diciembre 2024
PR Newswire (US)

SyntheticMR Receives Regulatory Approval for SyMRI 15 in Switzerland

SyntheticMR Receives Regulatory Approval for SyMRI 15 in Switzerland PR Newswire LINKÖPING, Sweden, Oct. 2, 2024 LINKÖPING, Sweden, Oct. 2, 2024 /PRNewswire/ -- SyntheticMR AB, global leader in...

02 Octubre 2024
PR Newswire (US)

SyntheticMR Announces the Appointment of Francois Hebert as New President, North America

SyntheticMR Announces the Appointment of Francois Hebert as New President, North America PR Newswire LINKÖPING, Sweden, Sept. 4, 2024 LINKÖPING, Sweden , Sept. 4, 2024 /PRNewswire/ -- SyntheticMR...

04 Septiembre 2024
PR Newswire (US)

SyMRI 15 by SyntheticMR obtains CE-Marking

SyMRI 15 by SyntheticMR obtains CE-Marking PR Newswire LINKÖPING, Sweden, June 26, 2024 SyntheticMR announced today that version 15 of their next-generation imaging solution, SyMRI Neuro, has...

26 Junio 2024
PR Newswire (US)

SyntheticMR and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR's SyMRI NEURO Software at SimonMed Facilities

SyntheticMR and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR's SyMRI NEURO Software at SimonMed Facilities PR...

17 Abril 2024
PR Newswire (US)

SyntheticMR receives FDA 510(k) clearance for their next Generation Solution SyMRI 3D

SyntheticMR receives FDA 510(k) clearance for their next Generation Solution SyMRI 3D PR Newswire LINKÖPING, Sweden, March 27, 2024 LINKÖPING, Sweden, March 27, 2024 /PRNewswire/ -- SyntheticMR...

27 Marzo 2024
PR Newswire (US)

Philips teams with SyntheticMR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients

Philips teams with SyntheticMR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients PR Newswire LINKÖPING, Sweden, March 1, 2024...

01 Marzo 2024
UK Regulatory

SyMRI 3D by SyntheticMR Set for Early 2024 Commercial Launch Post Obtaining CE-Marking

SyMRI 3D by SyntheticMR Set for Early 2024 Commercial Launch Post Obtaining CE-Marking PR Newswire LINKÖPING, Sweden, Dec. 18, 2023 LINKÖPING, Sweden, Dec. 18, 2023 /PRNewswire/ -- SyntheticMR...

18 Diciembre 2023
PR Newswire (US)

SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3D

SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3D PR Newswire LINKÖPING, Sweden, Nov. 30, 2023 LINKÖPING, Sweden, Nov. 30, 2023 /PRNewswire/ -- SyntheticMR announced today...

30 Noviembre 2023
PR Newswire (US)

SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3D

SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3D PR Newswire LINKÖPING, Sweden, Nov. 30, 2023 LINKÖPING, Sweden, Nov. 30, 2023 /PRNewswire/ -- SyntheticMR announced today...

30 Noviembre 2023
PR Newswire (US)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10035035035000DE
40035035035000DE
120035035035000DE
260035035035000DE
520035035035000DE
1560035035035000DE
2600035035035000DE

0G79 - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Syntheticmr Ab (publ)?
El precio actual de las acciones de Syntheticmr Ab (publ) es SEK 350.00
¿Cuántas acciones de Syntheticmr Ab (publ) están en circulación?
Syntheticmr Ab (publ) tiene 41,651,000 acciones en circulación
¿Cuál es la capitalización de mercado de Syntheticmr Ab (publ)?
La capitalización de mercado de Syntheticmr Ab (publ) es SEK 14.58B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Syntheticmr Ab (publ)?
Syntheticmr Ab (publ) ha negociado en un rango de SEK 350.00 a SEK 350.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Syntheticmr Ab (publ)?
El ratio precio/beneficio de Syntheticmr Ab (publ) es 1.46k
¿Cuál es el ratio de efectivo a ventas de Syntheticmr Ab (publ)?
El ratio de efectivo a ventas de Syntheticmr Ab (publ) es 163.41
¿Cuál es la moneda de reporte de Syntheticmr Ab (publ)?
Syntheticmr Ab (publ) presenta sus resultados financieros en SEK
¿Cuál es el último ingresos anual de Syntheticmr Ab (publ)?
El último ingresos anual de Syntheticmr Ab (publ) es SEK 89.21M
¿Cuál es el último beneficio anual de Syntheticmr Ab (publ)?
El último beneficio anual de Syntheticmr Ab (publ) es SEK 10.01M
¿Cuál es la dirección registrada de Syntheticmr Ab (publ)?
La dirección registrada de Syntheticmr Ab (publ) es GREV TUREGATAN 11C, STOCKHOLM, SE-114 46
¿Cuál es la dirección del sitio web de Syntheticmr Ab (publ)?
La dirección del sitio web de Syntheticmr Ab (publ) es www.syntheticmr.com
¿En qué sector industrial opera Syntheticmr Ab (publ)?
Syntheticmr Ab (publ) opera en el sector MEDICAL LABORATORIES

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discusión

Ver feed completo
Pittkid Pittkid 2 minutos hace
These guys are clowns...
HMBL
dstock07734 dstock07734 2 minutos hace
Gary,

I really doubt that keytruda was included in the UK specials program. But poly-iclc should be included for sure.
NWBO
OMOLIVES OMOLIVES 2 minutos hace
You left the fish out. I can't do those.
HMBL
nowwhat2 nowwhat2 2 minutos hace
Baseless, foundationless, amateurish pumping.......
GREAT !.....That is just what we need.
Thanks.


https://investorshub.advfn.com/uimage/uploads/2025/1/4/gwspeBTC_!_4_6M_9AM_CAPT_MAG_100K.jpg


.
BTCUSD
Louie_Louie Louie_Louie 3 minutos hace
Exactly, LOL QueenVic, I think he might just throw a line or two about it, but that would be enough to start the NYSE quaking.
crescentmotor crescentmotor 3 minutos hace
the MABs are irrelevant to the efficacy and eventual approval of Blarcamisine.

Not true. Once a drug demonstrates sufficient safety and efficacy to support approval, the regulatory process always considers existing approved drugs for the same indication and the comparative standards
AVXL
SSKILLZ1 SSKILLZ1 3 minutos hace
Individual Stocks Sorted Alphabetically

Commentary: Here are all the stocks that were picked. sorted alphabetically. Without further ado here is the list.
[pre]
Symbol # of Times Picked
1 $$ 6
2 ABRA.V 1
3 AES 2
4 AI 1
5 ALAR 1
AES AMRN APLD
georgejjl georgejjl 3 minutos hace
Look at the separation comparing the 50mg/day dose of blarcamesine to placebo for the CGI-I

"...One exploratory clinical endpoint specified in the protocol was also analyzed: the questionnaire-based Clinical Global Impression – Improvement (CGI-I) scale...."

"...CGI-I w
AVXL
frrol frrol 3 minutos hace
How many "world class"? Be wary of confirmation bias. And there's no reason to be afraid of investors. You'll be alright.
AVXL
fuagf fuagf 3 minutos hace
Judge upholds Trump’s felony conviction, but does not plan to order jail time

"Trump indictment follows 50 years of investigation on many fronts"

Related:
Trump hush money judge 'still has another couple of tricks up his sleeve': legal expert
Tom Boggion
williamssc williamssc 3 minutos hace
Shorts got together and have arrived in droves now that the fantastic peer review is out. No drug is perfect but Blarcamesine is darn close.
AVXL
jimr1717 jimr1717 4 minutos hace
This truck gave its life for us. I'll be getting another.

https://www.cybertruckownersclub.com/forum/threads/video-added-cybertruck-gave-its-life-for-us-in-collision-with-ford-explorer.20624/
TSLA
JuicePigs JuicePigs 4 minutos hace
You have said that about literally every single other podcast as well.
WDLF
newmedman newmedman 4 minutos hace
I can't even sign into twitter these days.. Something is really fucked up over there.
dstock07734 dstock07734 5 minutos hace
It is possible. But I recall CYT107 can increase both CD 4&8 t cell counts by four folds.
NWBO
haha11 haha11 5 minutos hace
$UPRO.....60...WKLY...

60.
https://schrts.co/nSfsMsty
WKLY..
https://schrts.co/fezBpxgV
UPRO
StockItOut StockItOut 6 minutos hace
Decent end-of-day volume. XERI is going higher. JohnnyDoeseph may break even soon in the 2s.
XERI
SSKILLZ1 SSKILLZ1 6 minutos hace
The Stocks And The # Of Times Picked In Pick 4 Contest #21

Commentary: As you can see lots of us Picked $$ in fact 6 of us have done so. So that is the sheepiest picks in Pick 4 Contest #21. There were 127 stocks picked for Pick 4 Contest #21. Without further ado here is list.
AES AMRN APLD
Mr. Bill Mr. Bill 7 minutos hace
Joy Joy Freezing rain
huang guo qing huang guo qing 8 minutos hace
Seventeen years have passed many people have died and those who are still alive have grown old the money invested is no longer meaningful the personal money has become state property socialism is killing people
FNMA
crescentmotor crescentmotor 8 minutos hace
Hearing from the painter, the pianist, or even the Nobel Laureate [at JPM] could be incredibly impactful.

Would the introduction of those anecdotal stories/testimonies at a conference like JPM be frowned upon by regulatory authorities?
JPM
jimr1717 jimr1717 9 minutos hace
Excellent! Sounds like many shares to gag on.

Getting your bids filled will become very easy shortly. No matter what size.
ATMH
StockItOut StockItOut 9 minutos hace
He might if you ask him. He mostly cannot read my posts, and Admin has required he not respond directly to me. Though he does read my posts when another post has multiple relies and mine is also one of those replies.
XERI
LOB LOB 9 minutos hace
Thanks. Sounds good. Surprised it didn't go up more on Friday. Maybe next week.
BCDS

Su Consulta Reciente

LSE
0G79
Syntheticmr Ab (publ)
AQSE
SXLK.GB
State Street Global Advi...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados